Findings identify D7 as a promising antiviral lead compound and provide a foundation for further mechanistic, optimization, and in vivo studies aimed at developing anti‐alphavirus therapeutics.
A. C. C. Reis, Amália Luíza de Sousa da Silva, Camila Portruneli et al.· Journal of Medical Virology· 0 citations
Among the tested compounds, derivative 6 demonstrated the most pronounced anti-CHIKV activity, with a low micromolar effective concentration and moderate selectivity index, and was identified as a potential lead candidate for further development against CHIKV.
A. C. C. Reis, Camila Portruneli, L. da Cunha Agostini et al.· Current Microbiology· 0 citations
Results identify PC1 as the most promising candidate for future preclinical development, whereas GNT and PA2 should be considered lead compounds for further optimization strategies aimed at improving selectivity and safety profiles.
Delaine Meireles Gouvêa, Maria Cecília Muniz de Souza Brand, Millena Alves Máximo Vaz et al.· ACS Omega· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.